The Claim
In adults with Graves' disease, the addition of Haizao Yuhu Decoction to methimazole is associated with a lower incidence of adverse events (5.56% vs 18.52%) over a 12-week period compared to methimazole monotherapy, with reductions primarily in liver injury and leukopenia.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with Graves' disease, combining Haizao Yuhu Decoction with methimazole results in fewer adverse events (5.56% vs 18.52%) over 12 weeks than methimazole alone, with lower rates of liver injury and leukopenia.
See the scientific wording
In adults with Graves' disease, adding Haizao Yuhu Decoction to methimazole is associated with a lower incidence of adverse events (5.56% vs 18.52%) over 12 weeks compared to methimazole monotherapy, primarily due to reduced rates of liver injury and leukopenia.
Herbal compounds in the decoction reduce thyroid hormone production by blocking iodine uptake and cutting off blood supply to the thyroid, which allows doctors to use less of the strong medicine. Lower doses of the strong medicine mean less damage to the liver and fewer white blood cells being destroyed, so patients have fewer side effects.
What the research says
1 studyPeople with Graves' disease who took a traditional Chinese herbal remedy along with their regular medicine had fewer side effects than those who took only the regular medicine. The study shows the combo worked better and was safer.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.